ABIO Company Profile and Key Details
ARCA biopharma, Inc.
ABIO Stock Price Chart
Stock Price Today
ARCA biopharma, Inc. (ABIO) stock surged +1,052.00%, trading at $28.80 on NASDAQ, up from the previous close of $2.50. The stock opened at $2.35, fluctuating between $2.25 and $28.80 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.
Company Information
| Employees | 3 |
| Beta | 0.9 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
ARCA biopharma, Inc. (NASDAQ: ABIO) stock price is $28.80 in the last trading session. During the trading session, ABIO stock reached the peak price of $28.80 while $2.25 was the lowest point it dropped to. The percentage change in ABIO stock occurred in the recent session was 1,052% while the dollar amount for the price change in ABIO stock was $26.30.
The NASDAQ listed ABIO is part of Biotechnology industry that operates in the broader Healthcare sector. ARCA biopharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Christopher D. Ozeroff
Senior Vice President, Gen. Counsel & Sec.
Dr. Debra Marshall FACC, M.D.
Chief Medical Officer
Mr. C. Jeffrey Dekker CPA
Chief Financial Officer
Mr. Thomas A. Keuer
Chief Operating Officer
ABIO's closing price is 1,181.77% higher than its 52-week low of $2.25 where as its distance from 52-week high of $53.88 is -46.55%.
Number of ABIO employees currently stands at 3.
Official Website of ABIO is: https://www.arcabio.com
ABIO could be contacted at phone 720 940 2200 and can also be accessed through its website. ABIO operates from 10170 Church Ranch Way, Westminster, CO 80021, United States.
ABIO stock volume for the day was 290.85K shares. The average number of ABIO shares traded daily for last 3 months was 13.86K.
The market value of ABIO currently stands at $34.82M with its latest stock price at $28.80 and 1.21M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com